Molinari Cristina, Clauser Paola, Girometti Rossano, Linda Anna, Cimino Elisa, Puglisi Fabio, Zuiani Chiara, Bazzocchi Massimo
Department of Medical and Biological Sciences, Institute of Diagnostic Radiology, Azienda Ospedaliero-Universitaria, "S.Maria della Misericordia", P.le Santa Maria della Misericordia, University of Udine, Udine, Italy.
Department of Oncology, Azienda Ospedaliero-Universitaria, "S.Maria della Misericordia", University of Udine, Udine, Italy.
Radiol Med. 2015 Oct;120(10):911-8. doi: 10.1007/s11547-015-0527-z. Epub 2015 Mar 17.
To evaluate whether the variation of the apparent diffusion coefficient (ADC) values obtained with DWI can predict elevated levels of Ki67 proliferation index and aggressive subtypes in patients with breast cancer.
Breast MRI studies of 115 patients (mean age 57.3 years, range 36-81 years) with a biopsy-proven breast cancers were evaluated in this retrospective IRB-approved study. Examinations were performed on a 1.5 T magnet and included a Single-Shot Echoplanar DWI sequence with b values of 0 and 1000 s/mm(2). For each target lesion, ADC was measured. ADC values were compared considering Ki67 status (≥20 % or <20 %), histology, grade (G1, G2 or G3) and clinical-pathological classification (Luminal A, Luminal B HER2-positive, Luminal B HER-2 negative, HER-2 enriched and Triple Negative). Mann-Whitney U test and Kruskal-Wallis test were used for comparisons and receiver operating characteristic (ROC) curves were obtained. Inter- and intra-reader variability was evaluated in a subset of 40 patients, using interclass correlation coefficient (ICC) and Bland-Altman plots.
Of 115 lesions, 53 (46.1 %) were assessed as Ki67 positive and 62 (53.9 %) as Ki67 negative. ADC values were significantly (p < 0.0001) lower in Ki67-positive patients (median 0.86 × 10(-3) mm(2)/s; interquartile range 0.75-0.92) compared to Ki67-negative (median 1.03 × 10(-3) mm(2)/s; interquartile range 0.92-1.13). Median ADC was also lower in G2 and G3 cancer and in the Luminal B Her2-negative subtype (p = 0.0015). No differences were found when evaluating histology. ROC curve showed a sensitivity and specificity of 83.0 and 66.1 %, respectively, when using a cutoff of 0.95 s/mm(2) to differentiate Ki67-positive from Ki67-negative cancers. Inter- and intra-reader variability was moderate (ICC = 0.623; ICC = 0.548, respectively). No systematic differences were identified with Bland-Altman plots.
Lower ADC values are associated with elevated Ki67 proliferation index and more aggressive pathologic features. Moderate agreement in ADC measurement could be a limitation.
评估弥散加权成像(DWI)获得的表观扩散系数(ADC)值的变化是否能够预测乳腺癌患者Ki67增殖指数升高及侵袭性亚型。
在这项经机构审查委员会(IRB)批准的回顾性研究中,对115例经活检证实患有乳腺癌的患者(平均年龄57.3岁,范围36 - 81岁)的乳腺MRI检查进行了评估。检查在1.5T磁体上进行,包括b值为0和1000 s/mm²的单次激发平面回波DWI序列。对每个目标病变测量ADC值。根据Ki67状态(≥20%或<20%)、组织学、分级(G1、G2或G3)和临床病理分类(腔面A型、腔面B型HER2阳性、腔面B型HER-2阴性、HER-2富集型和三阴性)比较ADC值。采用Mann-Whitney U检验和Kruskal-Wallis检验进行比较,并获得受试者操作特征(ROC)曲线。在40例患者的子集中,使用组内相关系数(ICC)和Bland-Altman图评估阅片者间和阅片者内的变异性。
115个病变中,53个(46.1%)被评估为Ki67阳性,62个(53.9%)为Ki67阴性。与Ki67阴性患者(中位数1.03×10⁻³mm²/s;四分位间距0.92 - 1.13)相比,Ki67阳性患者的ADC值显著更低(p < 0.0001)(中位数0.86×10⁻³mm²/s;四分位间距0.75 - 0.92)。G2和G3级癌症以及腔面B型Her2阴性亚型的ADC中位数也较低(p = 0.0015)。评估组织学时未发现差异。当使用0.95 s/mm²的临界值区分Ki67阳性和Ki67阴性癌症时,ROC曲线显示敏感性和特异性分别为83.0%和66.1%。阅片者间和阅片者内的变异性为中等(ICC分别为0.623和0.548)。Bland-Altman图未发现系统性差异。
较低的ADC值与升高的Ki67增殖指数和更具侵袭性的病理特征相关。ADC测量的中等一致性可能是一个局限。